Avoro Capital Advisors LLC Dbv Technologies S.A. Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.75 - $21.85 $310,500 - $1.18 Million
-54,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$16.81 - $24.58 $907,739 - $1.33 Million
54,000 New
54,000 $1.21 Million
Q4 2017

Feb 14, 2018
SELL
$20.9 - $49.36 $4.05 Million - $9.56 Million
-193,600 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$39.62 - $46.17 $7.67 Million - $8.94 Million
193,600
193,600 $8.22 Million

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $774M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email